Pramlintide

Peptide

Pramlintide is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for pramlintide is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Peptide
Suggested cadence
once daily

Research behind this entry

  1. Study reanalysis using a mechanism-based pharmacokinetic/pharmacodynamic model of pramlintide in subjects with type 1 diabetes. Fang J, Landersdorfer CB, Cirincione B, Jusko WJ · The AAPS journal, 2013 DOI

    This citation reports a human clinical study involving Pramlintide. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.

1 published study referenced in the app, each with a plain-language summary.